Gainers
- Camber Energy, Inc.. (NYSE:CEI) shares surged 95.9% to close at $1.78 on Thursday after dipping over 40% on Wednesday. Camber Energy filed amended 8K showing financial statements of Viking.
- Merus N.V. (NASDAQ:MRUS) jumped 37.5% to close at $27.49 as the company presented early clinical data on MCLA-158 and preclinical data on zenocutuzumab at AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics.
- New Fortress Energy Inc. (NYSE:NFE) shares climbed 25.5% to close at $33.26 after the company issued gas supply and economic guidance.
- Nutriband Inc. (NASDAQ:NTRB) gained 25.1% to close at $7.83. Nutriband's AVERSA Technology recently received Notice of Allowance from USPTO for application titled 'Abuse and Misuse Deterrent Transdermal Systems.'
- Aehr Test Systems (NASDAQ:AEHR) jumped 22.4% to close at $16.66 in sympathy with the overall market on optimism Congress will near a deal that would prevent a government shutdown.
- PEDEVCO Corp. (NYSE:PED) rose 21.5% to settle at $1.98 as a popular Twitter account Will Meade said is long stock.
- Burcon NutraScience Corporation (NASDAQ:BRCN) gained 20.4% to close at $1.65.
- Alpha Teknova, Inc. (NASDAQ:TKNO) rose 20.1% to settle at $26.13.
- Paltalk, Inc. (NASDAQ:PALT) shares gained 19.3% to settle at $8.27 after dropping over 15% on Wednesday. Paltalk’s recent filing showed registration for $50 million mixed securities shelf offering.
- Altisource Portfolio Solutions S.A. (NASDAQ:ASPS) climbed 18.3% to close at $11.75 as the company agreed to sell Pointillist subsidiary for $150 million.
- Amplify Energy Corp. (NYSE:AMPY) rose 17.2% to settle at $3.40.
- Bicycle Therapeutics plc (NASDAQ:BCYC) jumped 16.7% to close at $48.69. Bicycle Therapeutics reported interim Phase I trial results for BT5528 and preliminary findings from the ongoing dose-escalation portion of the BT8009 trial.
- Q&K International Group Limited (NASDAQ:QK) rose 16.7% to settle at $0.77.
- Xiaobai Maimai Inc. (NASDAQ:HX) gained 16.5% to close at $3.04.
- Theseus Pharmaceuticals, Inc. (NASDAQ:THRX) rose 16.1% to settle at $18.58 as the company priced its IPO at $16 per share.
- Richardson Electronics, Ltd. (NASDAQ:RELL) jumped 15.5% to close at $11.65 after reports first quarter fiscal 2022 net income of $2.6 million.
- Tata Motors Limited. (NYSE:TTM) gained 15.3% to close at $25.75 after Morgan Stanley upgraded the company's stock from Equal-Weight to Overweight.
- Resources Connection, Inc. (NASDAQ:RGP) climbed 15.2% to close at $19.25 following upbeat quarterly results.
- U.S. Silica Holdings, Inc. (NYSE:SLCA) surged 14.6% to close at $9.72 after the company announced it is commencing a review of strategic alternatives for its Industrial & Specialty Products segment.
- Yatsen Holding Limited (NYSE:YSG) rose 12.6% to settle at $4.10.
- Cyren Ltd. (NASDAQ:CYRN) gained 12.1% to settle at $0.5460 after the company announced Nasdaq granted its request for a 180-day extension to regain compliance with Nasdaq's minimum bid price requirement.
- Biotricity, Inc. (NASDAQ:BTCY) gained 11.6% to close at $3.09. Biotricity announced the launch of Biocare Cardiac application for Samsung's Galaxy Watch4 series.
- NeuroMetrix, Inc. (NASDAQ:NURO) gained 11.4% to close at $9.60. NeuroMetrix submitted a De Novo request to the FDA for Quell as a prescription treatment for fibromyalgia symptoms in adults. The Company received FDA Breakthrough Designation for this indication in July.
- Rocket Lab USA, Inc. (NASDAQ:RKLB) rose 10.4% to close at $15.46 after the company disclosed that it has been selected to launch NASA's Advanced Composite Solar Sail System.
- AppLovin Corporation (NASDAQ:APP) shares climbed 10.3% to close at $84.94. Twitter agreed to sell its MoPub mobile ad unit to AppLovin for $1.05 billion in cash.
- DatChat, Inc. (NASDAQ:DATS) gained 9.2% to close at $8.04 after dropping 17% on Wednesday.
- Levi Strauss & Co. (NYSE:LEVI) rose 8.5% to close at $26.29 as the company posted upbeat Q3 results and raised FY21 earnings forecast.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Check out these big penny stock gainers and losers
Losers
- Prelude Therapeutics Incorporated (NASDAQ:PRLD) shares dipped 39.8% to settle at $17.34 on Thursday. Prelude Therapeutics announced presentation of data from multiple programs at AACR-NCI-EORTC Virtual International Conference.
- Osmotica Pharmaceuticals plc (NASDAQ:OSMT) shares tumbled 37.6% to close at $1.91 on Thursday as the company priced its secondary public offering of 14 million shares and warrants to purchase up to 14 million shares at $2.5/piece.
- ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) fell 35.4% to close at $12.28 after the company presented initial clinical data from Phase 1b trial of ORIC-101 in combination with enzalutamide and preclinical data on ORIC-114 at AACR-NCI-EORTC.
- Turning Point Therapeutics, Inc. (NASDAQ:TPTX) fell 23.3% to close at $46.55. Turning Point Therapeutics presented updated preliminary clinical data for repotrectinib and elzovantinib at 2021 AACR-NCI-EORTC Conference and issued regulatory updates.
- Volcon, Inc. (NASDAQ:VLCN) fell 19.9% to close at $8.70. Volcon shares jumped over 97% on Wednesday as the company priced its IPO at $5.50 per share.
- Eliem Therapeutics, Inc. (NASDAQ:ELYM) dipped 14.4% to settle at $15.26.
- Forma Therapeutics Holdings, Inc. (NASDAQ:FMTX) fell 13.1% to close at $20.45. Forma Therapeutics reported initial results from a Phase 1 trial of its novel CBP/p300 inhibitor, the oral small molecule FT-7051, in men with metastatic castration-resistant prostate cancer.
- Repare Therapeutics Inc. (NASDAQ:RPTX) declined 12.2% to close at $21.90.
- Relay Therapeutics, Inc. (NASDAQ:RLAY) fell 11.9% to close at $26.00. Relay Therapeutics, shared preclinical data at the virtual AACR-NCI-EORTC Molecular Targets Conference for RLY-2608, the first allosteric, pan-mutant and isoform-selective PI3Kα inhibitor.
- The Joint Corp. (NASDAQ:JYNT) dropped 11.3% to settle at $85.53 after Bear Cave issued a short report.
- Cytosorbents Corporation (NASDAQ:CTSO) shares fell 9.8% to close at $7.20.
- Priority Technology Holdings, Inc. (NASDAQ:PRTH) declined 9.7% to close at $5.48.
- ATIF Holdings Limited (NASDAQ:ATIF) dropped 9.6% to close at $4.22.
- F45 Training Holdings Inc. (NYSE:FXLV) fell 8.9% to settle at $14.05.
- BP Prudhoe Bay Royalty Trust (NYSE:BPT) fell 8.8% to close at $3.73.
- NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) shares fell 7.9% to close at $7.79 after dropping over 4% on Wednesday. NRx Pharmaceuticals recently issued an update on NIH Sponsored ACTIV-3b critical care study.
- Xeris Pharmaceuticals, Inc. (NASDAQ:XERS) fell 6.8% to close at $2.20.
- Lamb Weston Holdings, Inc. (NYSE:LW) dropped 6.6% to close at $58.20 after reporting Q1 results.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.